Literature DB >> 30718829

Breaking the law: unconventional strategies for antibody diversification.

Alexia Kanyavuz1,2,3, Annaelle Marey-Jarossay1,2,3, Sébastien Lacroix-Desmazes1,2,3, Jordan D Dimitrov4,5,6.   

Abstract

Antibodies are essential components of adaptive immunity. A typical antibody repertoire comprises an enormous diversity of antigen-binding specificities, which are generated by the genetic processes of recombination and mutation. Accumulating evidence suggests that the immune system can exploit additional strategies to diversify the repertoire of antigen specificities. These unconventional mechanisms exclusively target the antigen-binding sites of immunoglobulins and include the insertion of large amino acid sequences, post-translational modifications, conformational heterogeneity and use of nonprotein cofactor molecules. Here, we describe the different unconventional routes for diversification of antibody specificities. Furthermore, we highlight how the immune system has a much greater level of adaptability and plasticity than previously anticipated, which goes far beyond that encoded in the genome or generated by the acquisition of somatic mutations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30718829     DOI: 10.1038/s41577-019-0126-7

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  120 in total

1.  Models for antigen receptor gene rearrangement: CDR3 length.

Authors:  Ravit Saada; Moran Weinberger; Gitit Shahaf; Ramit Mehr
Journal:  Immunol Cell Biol       Date:  2007-04-03       Impact factor: 5.126

Review 2.  Novel Approaches to Analyze Immunoglobulin Repertoires.

Authors:  Hedda Wardemann; Christian E Busse
Journal:  Trends Immunol       Date:  2017-05-26       Impact factor: 16.687

Review 3.  Assessing human B cell repertoire diversity and convergence.

Authors:  Katharina Imkeller; Hedda Wardemann
Journal:  Immunol Rev       Date:  2018-07       Impact factor: 12.988

Review 4.  Broadly neutralizing antiviral antibodies.

Authors:  Davide Corti; Antonio Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2013-01-16       Impact factor: 28.527

5.  LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes.

Authors:  L Meyaard; G J Adema; C Chang; E Woollatt; G R Sutherland; L L Lanier; J H Phillips
Journal:  Immunity       Date:  1997-08       Impact factor: 31.745

Review 6.  A cold-blooded view of adaptive immunity.

Authors:  Martin F Flajnik
Journal:  Nat Rev Immunol       Date:  2018-07       Impact factor: 53.106

Review 7.  Beyond binding: antibody effector functions in infectious diseases.

Authors:  Lenette L Lu; Todd J Suscovich; Sarah M Fortune; Galit Alter
Journal:  Nat Rev Immunol       Date:  2017-10-24       Impact factor: 53.106

Review 8.  On being the right size: antibody repertoire formation in the mouse and human.

Authors:  Andrew M Collins; Katherine J L Jackson
Journal:  Immunogenetics       Date:  2017-12-19       Impact factor: 2.846

Review 9.  Antibodies in HIV-1 vaccine development and therapy.

Authors:  Florian Klein; Hugo Mouquet; Pia Dosenovic; Johannes F Scheid; Louise Scharf; Michel C Nussenzweig
Journal:  Science       Date:  2013-09-13       Impact factor: 47.728

10.  A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens.

Authors:  Joshua Tan; Kathrin Pieper; Luca Piccoli; Peter Bull; Antonio Lanzavecchia; Abdirahman Abdi; Mathilde Foglierini Perez; Roger Geiger; Claire Maria Tully; David Jarrossay; Francis Maina Ndungu; Juliana Wambua; Philip Bejon; Chiara Silacci Fregni; Blanca Fernandez-Rodriguez; Sonia Barbieri; Siro Bianchi; Kevin Marsh; Vandana Thathy; Davide Corti; Federica Sallusto
Journal:  Nature       Date:  2015-12-23       Impact factor: 49.962

View more
  15 in total

Review 1.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

2.  Elevated N-Linked Glycosylation of IgG V Regions in Myasthenia Gravis Disease Subtypes.

Authors:  Caleigh Mandel-Brehm; Miriam L Fichtner; Ruoyi Jiang; Valerie J Winton; Sara E Vazquez; Minh C Pham; Kenneth B Hoehn; Neil L Kelleher; Richard J Nowak; Steven H Kleinstein; Michael R Wilson; Joseph L DeRisi; Kevin C O'Connor
Journal:  J Immunol       Date:  2021-09-20       Impact factor: 5.426

3.  Enhanced Pro-apoptotic Effects of Fe(II)-Modified IVIG on Human Neutrophils.

Authors:  Stefanie Graeter; Christoph Schneider; Daniëlle Verschoor; Sandro von Däniken; Frank Seibold; Nikhil Yawalkar; Peter Villiger; Jordan D Dimitrov; David F Smith; Richard D Cummings; Hans-Uwe Simon; Tchavdar Vassilev; Stephan von Gunten
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

4.  An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein.

Authors:  Andrew I Flyak; Stormy E Ruiz; Jordan Salas; Semi Rho; Justin R Bailey; Pamela J Bjorkman
Journal:  Elife       Date:  2020-03-03       Impact factor: 8.140

5.  Interaction of clinical-stage antibodies with heme predicts their physiochemical and binding qualities.

Authors:  Maxime Lecerf; Alexia Kanyavuz; Sofia Rossini; Jordan D Dimitrov
Journal:  Commun Biol       Date:  2021-03-23

Review 6.  Mechanisms of ligand binding.

Authors:  Enrico Di Cera
Journal:  Biophys Rev       Date:  2020-12

Review 7.  Context-dependent roles of complement in cancer.

Authors:  Lubka T Roumenina; Marie V Daugan; Florent Petitprez; Catherine Sautès-Fridman; Wolf Herman Fridman
Journal:  Nat Rev Cancer       Date:  2019-10-30       Impact factor: 60.716

Review 8.  Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire.

Authors:  Jing Yi Lai; Theam Soon Lim
Journal:  Int J Biol Macromol       Date:  2020-07-08       Impact factor: 6.953

9.  Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States.

Authors:  Evgeny A Ermakov; Georgy A Nevinsky; Valentina N Buneva
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

10.  Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation.

Authors:  Victoria Poillerat; Thomas Gentinetta; Juliette Leon; Andreas Wassmer; Monika Edler; Carine Torset; Dandan Luo; Gerald Tuffin; Lubka T Roumenina
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.